Matthew J. Brady
Concepts (408)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Adipocytes | 23 | 2015 | 155 | 4.620 |
Why?
| Glycogen | 17 | 2016 | 60 | 4.120 |
Why?
| Obesity | 12 | 2021 | 966 | 2.390 |
Why?
| Adipose Tissue | 10 | 2020 | 260 | 2.180 |
Why?
| Insulin Resistance | 8 | 2019 | 388 | 1.970 |
Why?
| Glycogen Synthase | 12 | 2016 | 22 | 1.640 |
Why?
| Bariatric Surgery | 3 | 2019 | 193 | 1.570 |
Why?
| Insulin | 17 | 2013 | 1169 | 1.520 |
Why?
| Intracellular Signaling Peptides and Proteins | 8 | 2016 | 384 | 1.360 |
Why?
| Glucose | 14 | 2014 | 625 | 1.210 |
Why?
| Weight Loss | 3 | 2019 | 234 | 1.190 |
Why?
| Circadian Rhythm | 2 | 2019 | 310 | 1.180 |
Why?
| Protein Phosphatase 1 | 8 | 2010 | 37 | 1.120 |
Why?
| Lipid Metabolism | 6 | 2013 | 212 | 1.110 |
Why?
| Adipogenesis | 3 | 2009 | 43 | 1.070 |
Why?
| Liver | 5 | 2013 | 1246 | 0.990 |
Why?
| Energy Metabolism | 6 | 2016 | 265 | 0.950 |
Why?
| Endocrine System | 2 | 2013 | 15 | 0.940 |
Why?
| Phosphoprotein Phosphatases | 9 | 2016 | 58 | 0.900 |
Why?
| Mice | 36 | 2021 | 11133 | 0.850 |
Why?
| Glycogenolysis | 2 | 2010 | 2 | 0.830 |
Why?
| Animals | 50 | 2021 | 26985 | 0.800 |
Why?
| Real-Time Polymerase Chain Reaction | 3 | 2019 | 286 | 0.800 |
Why?
| Incretins | 1 | 2019 | 15 | 0.790 |
Why?
| Bone Remodeling | 1 | 2019 | 27 | 0.780 |
Why?
| Gene Expression | 5 | 2019 | 1331 | 0.780 |
Why?
| Gonadal Steroid Hormones | 1 | 2019 | 54 | 0.770 |
Why?
| Eating | 2 | 2016 | 174 | 0.700 |
Why?
| Bone and Bones | 1 | 2019 | 268 | 0.690 |
Why?
| Adipose Tissue, Brown | 2 | 2016 | 72 | 0.670 |
Why?
| Adiposity | 2 | 2017 | 72 | 0.660 |
Why?
| Starvation | 1 | 2016 | 23 | 0.640 |
Why?
| Receptors, Glucocorticoid | 3 | 2015 | 116 | 0.630 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 98 | 0.610 |
Why?
| Gene Expression Profiling | 2 | 2019 | 1367 | 0.600 |
Why?
| Aniline Compounds | 2 | 2013 | 45 | 0.600 |
Why?
| Endocrine Disruptors | 2 | 2013 | 23 | 0.600 |
Why?
| Mammary Glands, Animal | 5 | 2020 | 80 | 0.590 |
Why?
| 3T3-L1 Cells | 8 | 2013 | 40 | 0.580 |
Why?
| Insulin Receptor Substrate Proteins | 3 | 2013 | 56 | 0.570 |
Why?
| Sleep Deprivation | 2 | 2013 | 144 | 0.560 |
Why?
| Diet, High-Fat | 4 | 2020 | 105 | 0.560 |
Why?
| Thermogenesis | 2 | 2013 | 24 | 0.550 |
Why?
| Adipose Tissue, White | 1 | 2013 | 17 | 0.530 |
Why?
| Growth Hormone | 1 | 2013 | 103 | 0.510 |
Why?
| Catecholamines | 1 | 2013 | 101 | 0.510 |
Why?
| Sulfonamides | 2 | 2013 | 329 | 0.500 |
Why?
| Receptor, Insulin | 3 | 2012 | 60 | 0.490 |
Why?
| Dioxins | 1 | 2012 | 1 | 0.490 |
Why?
| Phosphoenolpyruvate Carboxylase | 1 | 2012 | 2 | 0.490 |
Why?
| Polychlorinated Biphenyls | 1 | 2012 | 6 | 0.490 |
Why?
| Triglycerides | 2 | 2010 | 319 | 0.470 |
Why?
| Phosphorylation | 9 | 2016 | 1158 | 0.460 |
Why?
| Adrenal Gland Neoplasms | 2 | 2009 | 100 | 0.450 |
Why?
| Leptin | 6 | 2013 | 113 | 0.450 |
Why?
| Models, Biological | 5 | 2016 | 1798 | 0.440 |
Why?
| Thyroid Hormones | 1 | 2013 | 297 | 0.430 |
Why?
| Signal Transduction | 12 | 2019 | 3301 | 0.430 |
Why?
| Fatty Acids | 4 | 2018 | 146 | 0.430 |
Why?
| Hepatocytes | 6 | 2012 | 125 | 0.410 |
Why?
| Muscle, Skeletal | 4 | 2008 | 451 | 0.410 |
Why?
| Mice, Transgenic | 10 | 2018 | 1553 | 0.410 |
Why?
| Liver Glycogen | 1 | 2009 | 5 | 0.400 |
Why?
| Mice, Inbred C57BL | 9 | 2021 | 3180 | 0.380 |
Why?
| Protein Transport | 3 | 2013 | 420 | 0.360 |
Why?
| Glycogen Phosphorylase | 4 | 2016 | 6 | 0.350 |
Why?
| Cells, Cultured | 11 | 2021 | 2969 | 0.340 |
Why?
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2007 | 3 | 0.340 |
Why?
| Positron-Emission Tomography | 1 | 2009 | 273 | 0.340 |
Why?
| Humans | 29 | 2021 | 83447 | 0.310 |
Why?
| Hypoglycemic Agents | 3 | 2005 | 380 | 0.300 |
Why?
| Diabetes Mellitus, Type 2 | 5 | 2014 | 1286 | 0.300 |
Why?
| Chelating Agents | 1 | 2005 | 76 | 0.300 |
Why?
| Organometallic Compounds | 2 | 2005 | 135 | 0.290 |
Why?
| Male | 22 | 2021 | 41899 | 0.290 |
Why?
| 3T3 Cells | 5 | 2009 | 97 | 0.280 |
Why?
| Macrophages | 3 | 2020 | 556 | 0.280 |
Why?
| Dietary Fats | 2 | 2017 | 166 | 0.280 |
Why?
| Mammary Neoplasms, Animal | 3 | 2020 | 52 | 0.260 |
Why?
| Mammary Neoplasms, Experimental | 2 | 2016 | 126 | 0.260 |
Why?
| Peptide Elongation Factor 2 | 1 | 2003 | 6 | 0.260 |
Why?
| Proto-Oncogene Proteins c-akt | 4 | 2013 | 320 | 0.260 |
Why?
| Phosphoproteins | 1 | 2004 | 271 | 0.250 |
Why?
| Fasting | 3 | 2013 | 173 | 0.250 |
Why?
| Gene Expression Regulation | 7 | 2020 | 1941 | 0.250 |
Why?
| Mesentery | 2 | 2020 | 55 | 0.250 |
Why?
| Dose-Response Relationship, Drug | 5 | 2012 | 2100 | 0.240 |
Why?
| Nerve Growth Factors | 2 | 1993 | 68 | 0.230 |
Why?
| Adipokines | 2 | 2019 | 22 | 0.230 |
Why?
| Lactic Acid | 3 | 2012 | 119 | 0.230 |
Why?
| Serum Albumin | 1 | 2002 | 140 | 0.230 |
Why?
| Gluconeogenesis | 3 | 2012 | 14 | 0.220 |
Why?
| Laminin | 1 | 2021 | 86 | 0.220 |
Why?
| Bacterial Translocation | 1 | 2020 | 46 | 0.220 |
Why?
| Inflammation | 3 | 2015 | 824 | 0.210 |
Why?
| Carrier Proteins | 2 | 2006 | 685 | 0.210 |
Why?
| Diet, Fat-Restricted | 2 | 2018 | 40 | 0.210 |
Why?
| Needle-Exchange Programs | 1 | 2020 | 16 | 0.210 |
Why?
| Adenosine Triphosphate | 3 | 2012 | 310 | 0.200 |
Why?
| Female | 16 | 2021 | 44784 | 0.200 |
Why?
| Arteries | 1 | 2020 | 193 | 0.200 |
Why?
| Reference Standards | 1 | 2019 | 146 | 0.200 |
Why?
| Gene Silencing | 3 | 2010 | 183 | 0.190 |
Why?
| Fertility | 1 | 2019 | 94 | 0.190 |
Why?
| Pregnancy Complications, Infectious | 1 | 2020 | 131 | 0.190 |
Why?
| Protein Subunits | 3 | 2009 | 119 | 0.190 |
Why?
| Adenoviridae | 4 | 2010 | 348 | 0.180 |
Why?
| Young Adult | 4 | 2021 | 5970 | 0.180 |
Why?
| Cell Differentiation | 6 | 2018 | 1474 | 0.180 |
Why?
| Rats | 7 | 2018 | 4351 | 0.180 |
Why?
| Bone Density | 1 | 2019 | 215 | 0.180 |
Why?
| Magnetic Resonance Angiography | 1 | 2020 | 256 | 0.170 |
Why?
| Epithelial Cells | 3 | 2018 | 627 | 0.170 |
Why?
| Mutation | 1 | 2009 | 3862 | 0.170 |
Why?
| Hepatitis C | 1 | 2020 | 208 | 0.170 |
Why?
| Feeding Behavior | 1 | 2020 | 322 | 0.170 |
Why?
| Obesity, Morbid | 1 | 2019 | 211 | 0.170 |
Why?
| Enzyme Activation | 4 | 2005 | 737 | 0.170 |
Why?
| PPAR gamma | 2 | 2009 | 67 | 0.160 |
Why?
| CLOCK Proteins | 1 | 2016 | 14 | 0.160 |
Why?
| Tissue Distribution | 3 | 2006 | 302 | 0.160 |
Why?
| Oncogene Protein v-akt | 1 | 2016 | 22 | 0.160 |
Why?
| Binding Sites | 2 | 2010 | 1122 | 0.160 |
Why?
| Lipolysis | 2 | 2013 | 23 | 0.160 |
Why?
| Lung Neoplasms | 1 | 2009 | 2119 | 0.160 |
Why?
| Rats, Wistar | 4 | 2012 | 318 | 0.160 |
Why?
| Protein Binding | 4 | 2015 | 1509 | 0.160 |
Why?
| Toluidines | 2 | 2013 | 20 | 0.150 |
Why?
| Subcutaneous Fat | 1 | 2015 | 21 | 0.150 |
Why?
| Glucocorticoids | 2 | 2009 | 359 | 0.150 |
Why?
| Glucose Tolerance Test | 2 | 2013 | 241 | 0.150 |
Why?
| Lysophospholipids | 1 | 2016 | 66 | 0.150 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 2002 | 93 | 0.150 |
Why?
| Adult | 8 | 2021 | 25995 | 0.150 |
Why?
| Nuclear Receptor Co-Repressor 2 | 3 | 2010 | 24 | 0.150 |
Why?
| Transcription Factor 7-Like 2 Protein | 1 | 2014 | 29 | 0.140 |
Why?
| Treatment Outcome | 2 | 2019 | 7905 | 0.140 |
Why?
| Up-Regulation | 3 | 2021 | 712 | 0.140 |
Why?
| Stress, Psychological | 1 | 2018 | 308 | 0.140 |
Why?
| Rats, Sprague-Dawley | 3 | 2018 | 1370 | 0.140 |
Why?
| Glucose Intolerance | 1 | 2014 | 101 | 0.140 |
Why?
| Calmodulin-Binding Proteins | 1 | 1993 | 20 | 0.130 |
Why?
| Pituitary Gland | 1 | 2013 | 102 | 0.130 |
Why?
| Stem Cells | 2 | 2020 | 353 | 0.130 |
Why?
| Energy Intake | 1 | 2013 | 98 | 0.130 |
Why?
| Disease Models, Animal | 5 | 2021 | 2299 | 0.120 |
Why?
| Social Isolation | 1 | 2013 | 76 | 0.120 |
Why?
| Glucose-6-Phosphatase | 1 | 2012 | 8 | 0.120 |
Why?
| Mitochondria, Liver | 1 | 2012 | 27 | 0.120 |
Why?
| Receptors, Aryl Hydrocarbon | 1 | 2012 | 14 | 0.120 |
Why?
| Protein Kinases | 2 | 1993 | 224 | 0.120 |
Why?
| L-Lactate Dehydrogenase | 1 | 2012 | 68 | 0.120 |
Why?
| Phosphatidylinositol 3-Kinase | 1 | 2012 | 14 | 0.120 |
Why?
| Inflammation Mediators | 1 | 2013 | 158 | 0.120 |
Why?
| Glutathione Transferase | 2 | 2009 | 113 | 0.120 |
Why?
| Flavonoids | 1 | 2012 | 84 | 0.120 |
Why?
| Polysomnography | 1 | 2012 | 187 | 0.120 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 924 | 0.110 |
Why?
| Cross-Over Studies | 1 | 2012 | 414 | 0.110 |
Why?
| Fatty Acid-Binding Proteins | 2 | 2011 | 26 | 0.110 |
Why?
| Recombinant Fusion Proteins | 3 | 2009 | 571 | 0.110 |
Why?
| Immunoblotting | 2 | 2009 | 279 | 0.110 |
Why?
| Mitochondrial Proteins | 1 | 2012 | 118 | 0.110 |
Why?
| Cell Nucleus | 2 | 2013 | 589 | 0.110 |
Why?
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2010 | 3 | 0.110 |
Why?
| Calorimetry, Indirect | 1 | 2010 | 15 | 0.110 |
Why?
| Middle Aged | 6 | 2021 | 25596 | 0.110 |
Why?
| Specific Pathogen-Free Organisms | 1 | 2010 | 76 | 0.110 |
Why?
| Food Industry | 1 | 2010 | 2 | 0.100 |
Why?
| Fatty Acids, Nonesterified | 1 | 2010 | 85 | 0.100 |
Why?
| Endrin | 1 | 2009 | 1 | 0.100 |
Why?
| Phthalic Acids | 1 | 2009 | 3 | 0.100 |
Why?
| Receptors, Calcitriol | 1 | 2011 | 134 | 0.100 |
Why?
| Transfection | 2 | 2009 | 943 | 0.100 |
Why?
| Sympathetic Nervous System | 1 | 2010 | 113 | 0.100 |
Why?
| Estrogens, Non-Steroidal | 1 | 2009 | 31 | 0.100 |
Why?
| Phenols | 1 | 2009 | 39 | 0.100 |
Why?
| Immunohistochemistry | 3 | 2016 | 1823 | 0.100 |
Why?
| Benzhydryl Compounds | 1 | 2009 | 42 | 0.100 |
Why?
| Pheochromocytoma | 1 | 1990 | 67 | 0.100 |
Why?
| Luciferases | 1 | 2009 | 122 | 0.100 |
Why?
| Nuclear Proteins | 2 | 2005 | 697 | 0.100 |
Why?
| Blood Proteins | 1 | 2009 | 160 | 0.100 |
Why?
| Genes, Reporter | 1 | 2009 | 268 | 0.100 |
Why?
| Prednisone | 1 | 2009 | 264 | 0.100 |
Why?
| RNA, Messenger | 2 | 2013 | 1996 | 0.100 |
Why?
| Lipogenesis | 3 | 2013 | 22 | 0.090 |
Why?
| Blood Glucose | 1 | 2013 | 901 | 0.090 |
Why?
| Body Weight | 1 | 2010 | 503 | 0.090 |
Why?
| RNA Interference | 2 | 2007 | 378 | 0.090 |
Why?
| Mutation, Missense | 1 | 2010 | 276 | 0.090 |
Why?
| Genetic Vectors | 1 | 2010 | 449 | 0.090 |
Why?
| Gene Expression Regulation, Enzymologic | 2 | 2007 | 224 | 0.090 |
Why?
| Health Policy | 1 | 2010 | 170 | 0.090 |
Why?
| Environment | 1 | 2009 | 219 | 0.090 |
Why?
| Fluorodeoxyglucose F18 | 1 | 2009 | 126 | 0.090 |
Why?
| Magnetic Resonance Imaging | 2 | 2018 | 3267 | 0.090 |
Why?
| Prognosis | 1 | 2016 | 3709 | 0.090 |
Why?
| Cattle | 2 | 2002 | 378 | 0.090 |
Why?
| Radiopharmaceuticals | 1 | 2009 | 173 | 0.090 |
Why?
| Tumor Burden | 2 | 2020 | 287 | 0.090 |
Why?
| Pyruvic Acid | 1 | 2007 | 12 | 0.090 |
Why?
| Mice, Knockout | 3 | 2021 | 1953 | 0.080 |
Why?
| Sensitivity and Specificity | 2 | 2009 | 2080 | 0.080 |
Why?
| Phosphorylase a | 1 | 2006 | 1 | 0.080 |
Why?
| 1,4-alpha-Glucan Branching Enzyme | 1 | 2006 | 1 | 0.080 |
Why?
| Glycogen Debranching Enzyme System | 1 | 2006 | 3 | 0.080 |
Why?
| Mice, Inbred Strains | 1 | 2006 | 331 | 0.080 |
Why?
| Glucose Transporter Type 4 | 1 | 2006 | 17 | 0.080 |
Why?
| ROC Curve | 1 | 2009 | 761 | 0.080 |
Why?
| Glucose Transporter Type 1 | 1 | 2006 | 15 | 0.080 |
Why?
| RNA | 1 | 2010 | 515 | 0.080 |
Why?
| Pyrones | 1 | 2005 | 10 | 0.080 |
Why?
| Sleep | 1 | 2010 | 435 | 0.080 |
Why?
| Adenoma | 1 | 2008 | 266 | 0.080 |
Why?
| Phenotype | 2 | 2020 | 2295 | 0.080 |
Why?
| Vanadates | 1 | 2005 | 31 | 0.080 |
Why?
| Tumor Cells, Cultured | 2 | 2003 | 1088 | 0.080 |
Why?
| Solutions | 1 | 2005 | 93 | 0.080 |
Why?
| Lipids | 1 | 2008 | 387 | 0.080 |
Why?
| Kinetics | 2 | 2003 | 1622 | 0.080 |
Why?
| Radiographic Image Enhancement | 1 | 2008 | 466 | 0.080 |
Why?
| Repressor Proteins | 2 | 2009 | 409 | 0.070 |
Why?
| Tyrosine | 1 | 2005 | 147 | 0.070 |
Why?
| Glucokinase | 2 | 2004 | 58 | 0.070 |
Why?
| Genetic Testing | 1 | 2009 | 502 | 0.070 |
Why?
| Neural Crest | 1 | 2005 | 25 | 0.070 |
Why?
| Cell Proliferation | 3 | 2018 | 1613 | 0.070 |
Why?
| Melanocytes | 1 | 2005 | 58 | 0.070 |
Why?
| Membrane Proteins | 1 | 2012 | 1207 | 0.070 |
Why?
| Phosphorylases | 1 | 2004 | 4 | 0.070 |
Why?
| Deoxyglucose | 1 | 2004 | 38 | 0.070 |
Why?
| Molecular Structure | 1 | 2005 | 291 | 0.070 |
Why?
| Extracellular Fluid | 1 | 2004 | 23 | 0.070 |
Why?
| Aged, 80 and over | 3 | 2015 | 6577 | 0.070 |
Why?
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2008 | 463 | 0.070 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 180 | 0.070 |
Why?
| Drug Synergism | 1 | 2004 | 335 | 0.070 |
Why?
| RNA, Small Interfering | 1 | 2006 | 568 | 0.070 |
Why?
| Muscle Fibers, Skeletal | 1 | 2003 | 50 | 0.070 |
Why?
| Oligomycins | 1 | 2003 | 7 | 0.070 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2009 | 672 | 0.070 |
Why?
| Antimycin A | 1 | 2003 | 13 | 0.070 |
Why?
| Adenylate Kinase | 1 | 2003 | 12 | 0.070 |
Why?
| Predictive Value of Tests | 1 | 2009 | 1758 | 0.070 |
Why?
| Microscopy, Confocal | 1 | 2004 | 303 | 0.070 |
Why?
| Uridine Diphosphate Glucose | 1 | 2003 | 2 | 0.060 |
Why?
| Protein Phosphatase 2 | 1 | 2003 | 17 | 0.060 |
Why?
| Algorithms | 2 | 2009 | 1847 | 0.060 |
Why?
| Indicators and Reagents | 1 | 2003 | 78 | 0.060 |
Why?
| Methionine | 1 | 2003 | 66 | 0.060 |
Why?
| Muscle Denervation | 1 | 2002 | 3 | 0.060 |
Why?
| Cyclic AMP | 3 | 2004 | 280 | 0.060 |
Why?
| Islets of Langerhans | 2 | 2004 | 539 | 0.060 |
Why?
| Cysteine | 1 | 2003 | 135 | 0.060 |
Why?
| Substrate Specificity | 1 | 2003 | 371 | 0.060 |
Why?
| DNA-Binding Proteins | 2 | 2009 | 1212 | 0.060 |
Why?
| Proto-Oncogene Proteins | 2 | 2005 | 677 | 0.060 |
Why?
| Rabbits | 1 | 2003 | 716 | 0.060 |
Why?
| Retrospective Studies | 2 | 2020 | 7644 | 0.060 |
Why?
| Electrons | 1 | 2002 | 50 | 0.060 |
Why?
| Molecular Sequence Data | 1 | 2007 | 3194 | 0.060 |
Why?
| Antibodies | 1 | 2003 | 373 | 0.060 |
Why?
| Protein Kinase C | 1 | 2002 | 301 | 0.060 |
Why?
| Biological Transport | 1 | 2002 | 413 | 0.050 |
Why?
| Trans-Activators | 1 | 2004 | 446 | 0.050 |
Why?
| Models, Chemical | 1 | 2002 | 190 | 0.050 |
Why?
| Dexamethasone | 2 | 2015 | 314 | 0.050 |
Why?
| Oxidation-Reduction | 2 | 2012 | 379 | 0.050 |
Why?
| Protein Biosynthesis | 1 | 2003 | 379 | 0.050 |
Why?
| Hydrogen-Ion Concentration | 1 | 2002 | 554 | 0.050 |
Why?
| Germ-Free Life | 1 | 2020 | 82 | 0.050 |
Why?
| Ohio | 1 | 2020 | 39 | 0.050 |
Why?
| Regional Blood Flow | 1 | 2020 | 209 | 0.050 |
Why?
| Cell Polarity | 1 | 2020 | 120 | 0.050 |
Why?
| Metagenomics | 1 | 2020 | 89 | 0.050 |
Why?
| Ileum | 1 | 2020 | 191 | 0.050 |
Why?
| Metagenome | 1 | 2020 | 112 | 0.050 |
Why?
| RNA, Ribosomal, 16S | 1 | 2020 | 250 | 0.050 |
Why?
| Transcription, Genetic | 1 | 2005 | 1167 | 0.050 |
Why?
| Electron Spin Resonance Spectroscopy | 1 | 2002 | 303 | 0.050 |
Why?
| Organ Size | 1 | 2020 | 381 | 0.050 |
Why?
| Proteins | 1 | 2005 | 784 | 0.050 |
Why?
| Enzyme Inhibitors | 1 | 2003 | 674 | 0.050 |
Why?
| Adolescent | 1 | 2012 | 9140 | 0.050 |
Why?
| Time Factors | 3 | 2004 | 5496 | 0.050 |
Why?
| Lipopolysaccharides | 1 | 2020 | 277 | 0.050 |
Why?
| Mitochondria | 1 | 2003 | 532 | 0.050 |
Why?
| Neoplasm Invasiveness | 1 | 2020 | 532 | 0.050 |
Why?
| Mice, Mutant Strains | 2 | 2011 | 252 | 0.050 |
Why?
| Biodiversity | 1 | 2020 | 207 | 0.050 |
Why?
| Ligands | 2 | 2013 | 427 | 0.040 |
Why?
| Fructose | 1 | 2018 | 35 | 0.040 |
Why?
| Pregnancy Outcome | 1 | 2020 | 272 | 0.040 |
Why?
| Tomography, X-Ray Computed | 1 | 2008 | 2569 | 0.040 |
Why?
| Cell Line | 1 | 2003 | 2615 | 0.040 |
Why?
| Weaning | 1 | 2017 | 24 | 0.040 |
Why?
| United States | 1 | 2010 | 6316 | 0.040 |
Why?
| Random Allocation | 1 | 2018 | 376 | 0.040 |
Why?
| Kidney | 1 | 2003 | 1234 | 0.040 |
Why?
| Thiazolidinediones | 2 | 2009 | 92 | 0.040 |
Why?
| Receptors, Thyroid Hormone | 2 | 2009 | 161 | 0.040 |
Why?
| Logistic Models | 1 | 2020 | 1158 | 0.040 |
Why?
| Imaging, Three-Dimensional | 1 | 2020 | 584 | 0.040 |
Why?
| Culture Media, Conditioned | 1 | 2016 | 104 | 0.040 |
Why?
| Prevalence | 1 | 2020 | 1264 | 0.040 |
Why?
| Chromatin Immunoprecipitation | 1 | 2015 | 133 | 0.040 |
Why?
| Promoter Regions, Genetic | 2 | 2011 | 942 | 0.040 |
Why?
| Longitudinal Studies | 1 | 2018 | 988 | 0.030 |
Why?
| Aged | 2 | 2009 | 18508 | 0.030 |
Why?
| Dermatitis, Occupational | 1 | 1993 | 2 | 0.030 |
Why?
| Rubber | 1 | 1993 | 6 | 0.030 |
Why?
| Gloves, Surgical | 1 | 1993 | 7 | 0.030 |
Why?
| Glucose-6-Phosphate | 2 | 2004 | 2 | 0.030 |
Why?
| Calcimycin | 1 | 1993 | 40 | 0.030 |
Why?
| Ionomycin | 1 | 1993 | 29 | 0.030 |
Why?
| Receptors, Estrogen | 1 | 2016 | 382 | 0.030 |
Why?
| Crohn Disease | 1 | 2020 | 721 | 0.030 |
Why?
| Carbachol | 1 | 1993 | 39 | 0.030 |
Why?
| Caloric Tests | 1 | 2013 | 4 | 0.030 |
Why?
| Bradykinin | 1 | 1993 | 51 | 0.030 |
Why?
| Infant, Newborn | 1 | 2020 | 2438 | 0.030 |
Why?
| Colitis, Ulcerative | 1 | 2020 | 692 | 0.030 |
Why?
| Safflower Oil | 1 | 2013 | 13 | 0.030 |
Why?
| Thionucleotides | 1 | 1993 | 59 | 0.030 |
Why?
| PC12 Cells | 1 | 1993 | 121 | 0.030 |
Why?
| Gonads | 1 | 2013 | 23 | 0.030 |
Why?
| Antigens, Polyomavirus Transforming | 1 | 2013 | 50 | 0.030 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 1993 | 154 | 0.030 |
Why?
| Nursing Staff, Hospital | 1 | 1993 | 46 | 0.030 |
Why?
| Calmodulin | 1 | 1993 | 49 | 0.030 |
Why?
| Hypersensitivity, Immediate | 1 | 1993 | 62 | 0.030 |
Why?
| Fibroblast Growth Factor 2 | 1 | 1993 | 68 | 0.030 |
Why?
| Milk | 1 | 2013 | 49 | 0.030 |
Why?
| Epidermal Growth Factor | 1 | 1993 | 123 | 0.030 |
Why?
| Cytosol | 1 | 1993 | 194 | 0.030 |
Why?
| Corticosterone | 1 | 2013 | 34 | 0.030 |
Why?
| Response Elements | 1 | 2013 | 66 | 0.030 |
Why?
| Food | 1 | 2013 | 85 | 0.030 |
Why?
| Pregnancy | 1 | 2020 | 2818 | 0.030 |
Why?
| Medical Staff, Hospital | 1 | 1993 | 113 | 0.030 |
Why?
| Weight Gain | 1 | 2013 | 138 | 0.030 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 409 | 0.030 |
Why?
| AMP-Activated Protein Kinases | 1 | 2012 | 62 | 0.030 |
Why?
| Biological Transport, Active | 1 | 2011 | 104 | 0.030 |
Why?
| Sequence Analysis, DNA | 1 | 2015 | 890 | 0.030 |
Why?
| Oxygen Consumption | 1 | 2012 | 250 | 0.030 |
Why?
| Fatty Liver | 1 | 2012 | 123 | 0.030 |
Why?
| Feces | 1 | 2013 | 356 | 0.030 |
Why?
| Organ Specificity | 1 | 2011 | 260 | 0.030 |
Why?
| Peroxisome Proliferator-Activated Receptors | 1 | 2010 | 7 | 0.030 |
Why?
| Locomotion | 1 | 2011 | 112 | 0.030 |
Why?
| 1-Methyl-3-isobutylxanthine | 1 | 1990 | 19 | 0.030 |
Why?
| Elongation Factor 2 Kinase | 1 | 1990 | 7 | 0.030 |
Why?
| Insulin-Secreting Cells | 1 | 2014 | 405 | 0.030 |
Why?
| Oxidative Stress | 1 | 2013 | 412 | 0.030 |
Why?
| Colon | 1 | 2013 | 502 | 0.020 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2010 | 123 | 0.020 |
Why?
| Bacteria | 1 | 2013 | 444 | 0.020 |
Why?
| Computational Biology | 1 | 2013 | 530 | 0.020 |
Why?
| Heterozygote | 1 | 2010 | 374 | 0.020 |
Why?
| Mutagenesis, Site-Directed | 1 | 2009 | 282 | 0.020 |
Why?
| Plasmids | 1 | 2009 | 296 | 0.020 |
Why?
| Down-Regulation | 1 | 1990 | 524 | 0.020 |
Why?
| Models, Molecular | 1 | 2013 | 1310 | 0.020 |
Why?
| DNA Primers | 1 | 2009 | 571 | 0.020 |
Why?
| Cloning, Molecular | 1 | 2009 | 681 | 0.020 |
Why?
| Amino Acid Substitution | 1 | 2009 | 359 | 0.020 |
Why?
| Fibroblasts | 1 | 2010 | 731 | 0.020 |
Why?
| Rats, Zucker | 1 | 2006 | 39 | 0.020 |
Why?
| Receptors, Leptin | 1 | 2006 | 34 | 0.020 |
Why?
| Apoptosis | 1 | 2013 | 1775 | 0.020 |
Why?
| Wnt3 Protein | 1 | 2005 | 13 | 0.020 |
Why?
| Wnt1 Protein | 1 | 2005 | 25 | 0.020 |
Why?
| Wnt3A Protein | 1 | 2005 | 23 | 0.020 |
Why?
| Nuclear Receptor Co-Repressor 1 | 1 | 2005 | 24 | 0.020 |
Why?
| Phosphorylase Kinase | 1 | 2004 | 1 | 0.020 |
Why?
| Antigens, Differentiation | 1 | 2005 | 146 | 0.020 |
Why?
| CREB-Binding Protein | 1 | 2004 | 16 | 0.020 |
Why?
| Gluconates | 1 | 2004 | 14 | 0.020 |
Why?
| Transcription Factors | 1 | 2013 | 1517 | 0.020 |
Why?
| Wnt Proteins | 1 | 2005 | 129 | 0.020 |
Why?
| Amides | 1 | 2004 | 61 | 0.020 |
Why?
| Receptors, Cell Surface | 1 | 2006 | 296 | 0.020 |
Why?
| Glucagon | 1 | 2004 | 117 | 0.020 |
Why?
| Second Messenger Systems | 1 | 2004 | 41 | 0.020 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 59 | 0.020 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 305 | 0.020 |
Why?
| Muscles | 1 | 2004 | 196 | 0.020 |
Why?
| Cell Lineage | 1 | 2005 | 288 | 0.020 |
Why?
| Muscle, Smooth | 1 | 2005 | 371 | 0.020 |
Why?
| Hydrolysis | 1 | 2003 | 154 | 0.020 |
Why?
| Hexokinase | 1 | 2002 | 19 | 0.020 |
Why?
| Brain | 1 | 1993 | 2160 | 0.020 |
Why?
| Glycogen Synthase Kinase 3 | 1 | 2002 | 61 | 0.020 |
Why?
| Indoles | 1 | 2004 | 335 | 0.010 |
Why?
| Recombinant Proteins | 1 | 2004 | 1064 | 0.010 |
Why?
| Reproducibility of Results | 1 | 2008 | 2674 | 0.010 |
Why?
| Protein Structure, Tertiary | 1 | 2003 | 766 | 0.010 |
Why?
| Reference Values | 1 | 2002 | 702 | 0.010 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2001 | 323 | 0.010 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2005 | 655 | 0.010 |
Why?
| Angioedema | 1 | 1993 | 4 | 0.010 |
Why?
| Bronchial Spasm | 1 | 1993 | 16 | 0.010 |
Why?
| Dermatitis, Allergic Contact | 1 | 1993 | 7 | 0.010 |
Why?
| Anaphylaxis | 1 | 1993 | 34 | 0.010 |
Why?
| Immunoglobulin E | 1 | 1993 | 143 | 0.010 |
Why?
| Emergencies | 1 | 1993 | 109 | 0.010 |
Why?
|
|
Brady's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|